Isolation and characterization of the immune cell fraction from murine brain tumor microenvironment

STAR Protoc. 2022 Jan 20;3(1):101106. doi: 10.1016/j.xpro.2021.101106. eCollection 2022 Mar 18.

Abstract

The immune fraction of the tumor microenvironment has been proven to play a fundamental role in glioblastoma progression and therapeutic response. Here, we present a detailed magnetic-bead-enrichment-based protocol to isolate and analyze the composition of this fraction from mouse brain tumors. The protocol is optimized to achieve high yields of viable immune cells. We also detail characterization of the immune subtypes by FACS analysis. Our procedure is applicable for either lentiviral-induced tumors or transplant models in syngeneic immunocompetent mice. For complete details on the use and execution of this protocol, please refer to Magod et al. (2021).

Keywords: Cancer; Cell Biology; Cell isolation; Flow Cytometry/Mass Cytometry; Immunology; Model Organisms; Neuroscience.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Neoplasms / immunology*
  • Brain Neoplasms / pathology
  • Disease Models, Animal
  • Flow Cytometry
  • Mice
  • Tumor Microenvironment*